The signal peptide as a new target for drug design: SAR and PK of novel protein down-modulators by Prof. Thomas Bell, PhD Department of Chemistry University of Nevada, Reno
Hybrid therapeutic discovery: a journey from academia to industry by Dr.Chawita Netirojjanakul, Senior Scientist,Amgent,USA.
Venue: Room M106, MSE Building,VISTEC
Date: 14th, January 2019
Time: 10.00-11.45 hrs.